A 68-year-old patient came to the Infectious Diseases Outpatient Clinic with a diagnosis
of chronic hepatitis C, and F3 fibrosis confirmed in elastographic examination. He also
suffers from ischemic heart disease. Indicate the adequate statement on the
recommended treatment and prognosis:
A. treatment of chronic HCV infections is limited to pegylated interferon which allows full
recovery in 90% of patients, but such treatment is contraindicated in the patient
because of their ischemic heart disease.
B. the patient will not be treated because in Poland antiviral treatment of chronic
hepatitis C is not covered by the National Health Fund for patients older than 65.
C. treatment with pegylated interferon α associated with ribavirin and telaprevir for 11
months, which leads to sustained virologic response (SVR) in 80% of all treated, is
optimal treatment currently recommended for the majority of patients, regardless of any
comorbidities.
D. patient does not need any antiviral treatment because of an early stage of liver
fibrosis.
E. oral therapy with two or three medications directly inhibiting HCV replication, which is
aimed at curing HCV infection (genotype 1) in over 90% of cases
Dział:
Interna
Odpowiedź na to pytanie oraz inne pytania z tego samego działu znajdziesz w aplikacji Egzamin LEK
